FALSE0001121404--12-316/30/20232023Q200011214042023-01-012023-06-3000011214042023-06-30iso4217:EUR00011214042022-12-3100011214042022-01-012022-06-3000011214042022-01-012022-12-31xbrli:sharesiso4217:EURxbrli:shares0001121404ifrs-full:IssuedCapitalMember2021-12-310001121404ifrs-full:AdditionalPaidinCapitalMember2021-12-310001121404ifrs-full:TreasurySharesMember2021-12-310001121404ifrs-full:RetainedEarningsMember2021-12-310001121404ifrs-full:ReserveOfSharebasedPaymentsMember2021-12-310001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMember2021-12-310001121404ifrs-full:EquityAttributableToOwnersOfParentMember2021-12-310001121404ifrs-full:NoncontrollingInterestsMember2021-12-3100011214042021-12-310001121404ifrs-full:RetainedEarningsMember2022-01-012022-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-06-300001121404ifrs-full:EquityAttributableToOwnersOfParentMember2022-01-012022-06-300001121404ifrs-full:NoncontrollingInterestsMember2022-01-012022-06-300001121404sny:EuroapiMember2022-05-102022-05-10xbrli:pure0001121404ifrs-full:TreasurySharesMember2022-01-012022-06-300001121404ifrs-full:IssuedCapitalMember2022-01-012022-06-300001121404ifrs-full:AdditionalPaidinCapitalMember2022-01-012022-06-300001121404ifrs-full:ReserveOfSharebasedPaymentsMember2022-01-012022-06-300001121404ifrs-full:IssuedCapitalMember2022-06-300001121404ifrs-full:AdditionalPaidinCapitalMember2022-06-300001121404ifrs-full:TreasurySharesMember2022-06-300001121404ifrs-full:RetainedEarningsMember2022-06-300001121404ifrs-full:ReserveOfSharebasedPaymentsMember2022-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-06-300001121404ifrs-full:EquityAttributableToOwnersOfParentMember2022-06-300001121404ifrs-full:NoncontrollingInterestsMember2022-06-3000011214042022-06-300001121404ifrs-full:RetainedEarningsMember2022-07-012022-12-310001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-12-310001121404ifrs-full:EquityAttributableToOwnersOfParentMember2022-07-012022-12-310001121404ifrs-full:NoncontrollingInterestsMember2022-07-012022-12-3100011214042022-07-012022-12-310001121404ifrs-full:TreasurySharesMember2022-07-012022-12-310001121404ifrs-full:IssuedCapitalMember2022-07-012022-12-310001121404ifrs-full:AdditionalPaidinCapitalMember2022-07-012022-12-310001121404ifrs-full:ReserveOfSharebasedPaymentsMember2022-07-012022-12-310001121404ifrs-full:IssuedCapitalMember2022-12-310001121404ifrs-full:AdditionalPaidinCapitalMember2022-12-310001121404ifrs-full:TreasurySharesMember2022-12-310001121404ifrs-full:RetainedEarningsMember2022-12-310001121404ifrs-full:ReserveOfSharebasedPaymentsMember2022-12-310001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-12-310001121404ifrs-full:EquityAttributableToOwnersOfParentMember2022-12-310001121404ifrs-full:NoncontrollingInterestsMember2022-12-310001121404ifrs-full:RetainedEarningsMember2023-01-012023-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-06-300001121404ifrs-full:EquityAttributableToOwnersOfParentMember2023-01-012023-06-300001121404ifrs-full:NoncontrollingInterestsMember2023-01-012023-06-300001121404ifrs-full:TreasurySharesMember2023-01-012023-06-300001121404ifrs-full:AdditionalPaidinCapitalMember2023-01-012023-06-300001121404ifrs-full:IssuedCapitalMember2023-01-012023-06-300001121404ifrs-full:ReserveOfSharebasedPaymentsMember2023-01-012023-06-300001121404ifrs-full:IssuedCapitalMember2023-06-300001121404ifrs-full:AdditionalPaidinCapitalMember2023-06-300001121404ifrs-full:TreasurySharesMember2023-06-300001121404ifrs-full:RetainedEarningsMember2023-06-300001121404ifrs-full:ReserveOfSharebasedPaymentsMember2023-06-300001121404ifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-06-300001121404ifrs-full:EquityAttributableToOwnersOfParentMember2023-06-300001121404ifrs-full:NoncontrollingInterestsMember2023-06-300001121404sny:CommercialPaperProgramInUSAMember2023-01-012023-06-300001121404country:AR2023-06-300001121404country:TR2023-06-300001121404sny:CollaborationAgreementWithGSKMember2022-12-310001121404sny:CollaborationAgreementWithGSKMember2023-01-012023-06-300001121404sny:CollaborationAgreementWithGSKMembersny:USGovernmentMember2023-01-012023-06-300001121404sny:CollaborationAgreementWithGSKMembersny:USGovernmentMember2022-01-012022-12-310001121404sny:ProventionBioIncMember2023-03-13iso4217:USDxbrli:sharesiso4217:USD0001121404sny:ProventionBioIncMember2023-03-130001121404sny:ProventionBioIncMember2023-04-270001121404sny:ProventionBioIncMember2023-01-012023-06-300001121404sny:AntibodiesCollaborationAgreementMembersny:AstraZenecaMember2017-03-012017-03-310001121404sny:AntibodiesCollaborationAgreementMembersny:AstraZenecaMember2019-07-012019-09-300001121404sny:AntibodiesCollaborationAgreementMembersny:AstraZenecaMember2022-11-012022-11-300001121404sny:AntibodiesCollaborationAgreementMembersny:AstraZenecaMember2023-06-300001121404sny:MajorTerritoriesMembersny:AntibodiesCollaborationAgreementMembersny:AstraZenecaMember2023-01-012023-06-300001121404sny:AntibodiesCollaborationAgreementMembersny:AstraZenecaMembersny:OtherTerritoriesMember2023-01-012023-06-300001121404sny:AntibodiesCollaborationAgreementMembersny:AstraZenecaMember2023-01-012023-06-300001121404sny:AntibodiesCollaborationAgreementMembersny:AstraZenecaMembersny:OtherIntangibleAssetsExcludingSoftwareMember2023-04-092023-04-090001121404sny:AntibodiesCollaborationAgreementMembersny:SwedishOrphanBiovitrumABMember2023-04-090001121404sny:AntibodiesCollaborationAgreementMembercountry:CNsny:AstraZenecaMember2023-01-012023-06-300001121404sny:AntibodiesCollaborationAgreementMembersny:MajorFinancialLiabilityMembersny:SwedishOrphanBiovitrumABMember2023-07-172023-07-170001121404sny:AntibodiesCollaborationAgreementMembersny:AstraZenecaMembersny:MajorFinancialLiabilityMembersny:OtherIntangibleAssetsExcludingSoftwareMember2023-07-172023-07-170001121404sny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMember2022-01-012022-12-310001121404sny:BiopharmaSegmentMembersny:ManufacturingAndSupplyMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:ManufacturingAndSupplyMember2022-01-012022-12-310001121404sny:ConsumerHealthcareSegmentMember2023-01-012023-06-300001121404sny:ConsumerHealthcareSegmentMember2022-01-012022-12-310001121404sny:ConsumerHealthcareSegmentMembersny:ManufacturingAndSupplyMember2023-01-012023-06-300001121404sny:ConsumerHealthcareSegmentMembersny:ManufacturingAndSupplyMember2022-01-012022-12-31sny:segment0001121404sny:AcquiredResearchAndDevelopmentMemberifrs-full:GrossCarryingAmountMember2022-12-310001121404sny:ProductsTrademarksAndOtherRightsMemberifrs-full:GrossCarryingAmountMember2022-12-310001121404ifrs-full:ComputerSoftwareMemberifrs-full:GrossCarryingAmountMember2022-12-310001121404ifrs-full:GrossCarryingAmountMember2022-12-310001121404sny:AcquiredResearchAndDevelopmentMemberifrs-full:GrossCarryingAmountMember2023-01-012023-06-300001121404sny:ProductsTrademarksAndOtherRightsMemberifrs-full:GrossCarryingAmountMember2023-01-012023-06-300001121404ifrs-full:ComputerSoftwareMemberifrs-full:GrossCarryingAmountMember2023-01-012023-06-300001121404ifrs-full:GrossCarryingAmountMember2023-01-012023-06-300001121404sny:AcquiredResearchAndDevelopmentMemberifrs-full:GrossCarryingAmountMember2023-06-300001121404sny:ProductsTrademarksAndOtherRightsMemberifrs-full:GrossCarryingAmountMember2023-06-300001121404ifrs-full:ComputerSoftwareMemberifrs-full:GrossCarryingAmountMember2023-06-300001121404ifrs-full:GrossCarryingAmountMember2023-06-300001121404sny:AcquiredResearchAndDevelopmentMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2022-12-310001121404sny:ProductsTrademarksAndOtherRightsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2022-12-310001121404ifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2022-12-310001121404ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2022-12-310001121404sny:AcquiredResearchAndDevelopmentMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2023-01-012023-06-300001121404sny:ProductsTrademarksAndOtherRightsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2023-01-012023-06-300001121404ifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2023-01-012023-06-300001121404ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2023-01-012023-06-300001121404sny:AcquiredResearchAndDevelopmentMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2023-06-300001121404sny:ProductsTrademarksAndOtherRightsMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2023-06-300001121404ifrs-full:ComputerSoftwareMemberifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2023-06-300001121404ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember2023-06-300001121404sny:AcquiredResearchAndDevelopmentMember2022-12-310001121404sny:ProductsTrademarksAndOtherRightsMember2022-12-310001121404ifrs-full:ComputerSoftwareMember2022-12-310001121404sny:AcquiredResearchAndDevelopmentMember2023-06-300001121404sny:ProductsTrademarksAndOtherRightsMember2023-06-300001121404ifrs-full:ComputerSoftwareMember2023-06-300001121404sny:AltuviiioMember2023-01-012023-06-300001121404sny:OtherIntangibleAssetsExcludingSoftwareMember2023-01-012023-06-300001121404sny:AntibodiesCollaborationAgreementMembersny:AstraZenecaMembersny:OtherIntangibleAssetsExcludingSoftwareMember2023-04-112023-04-110001121404sny:MarketedProductsMember2023-06-300001121404sny:MarketedProductsMember2022-12-310001121404sny:MarketedProductsMember2023-01-012023-06-300001121404sny:TechnologicalPlatformsMember2023-06-300001121404sny:TechnologicalPlatformsMember2022-12-310001121404sny:TechnologicalPlatformsMember2023-01-012023-06-300001121404sny:EuroapiMember2023-01-012023-06-300001121404sny:EuroapiMember2023-06-300001121404sny:EuroapiMember2022-12-310001121404sny:InfraservGmbhAndCoHochstKGMember2023-01-012023-06-300001121404sny:InfraservGmbhAndCoHochstKGMember2023-06-300001121404sny:InfraservGmbhAndCoHochstKGMember2022-12-310001121404sny:MSPVaccineCompanyMember2023-01-012023-06-300001121404sny:MSPVaccineCompanyMember2023-06-300001121404sny:MSPVaccineCompanyMember2022-12-310001121404ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember2023-01-012023-06-300001121404ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember2023-06-300001121404ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember2022-12-310001121404sny:EuroapiMember2023-06-300001121404sny:MSPVaccineCompanyMembersny:MCMVaccineBVMember2023-01-012023-06-300001121404sny:AssociatesAndJointVenturesMember2023-01-012023-06-300001121404sny:AssociatesAndJointVenturesMember2022-01-012022-06-300001121404sny:AssociatesAndJointVenturesMember2022-01-012022-12-310001121404sny:AssociatesAndJointVenturesMember2023-06-300001121404sny:AssociatesAndJointVenturesMember2022-06-300001121404sny:AssociatesAndJointVenturesMember2022-12-310001121404ifrs-full:TradingEquitySecuritiesMember2023-06-300001121404ifrs-full:TradingEquitySecuritiesMember2022-12-310001121404ifrs-full:DebtSecuritiesMember2023-06-300001121404ifrs-full:DebtSecuritiesMember2022-12-310001121404ifrs-full:AllowanceForCreditLossesMember2023-06-300001121404ifrs-full:AllowanceForCreditLossesMember2022-12-310001121404ifrs-full:NotLaterThanOneMonthMember2023-06-300001121404ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember2023-06-300001121404ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember2023-06-300001121404ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember2023-06-300001121404ifrs-full:LaterThanOneYearMember2023-06-300001121404ifrs-full:NotLaterThanOneMonthMember2022-12-310001121404ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember2022-12-310001121404ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember2022-12-310001121404ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember2022-12-310001121404ifrs-full:LaterThanOneYearMember2022-12-310001121404ifrs-full:IssuedCapitalMembersny:SanofiMember2023-01-012023-06-300001121404sny:ShareRepurchase2022ProgramMember2022-05-032022-05-030001121404sny:ShareRepurchase2022ProgramMember2023-01-012023-06-300001121404sny:ShareRepurchase2023ProgramMember2023-05-252023-05-250001121404sny:RestrictedSharePlan2023Member2023-01-012023-06-300001121404sny:RestrictedSharePlan2023Membersny:WithoutMarketConditionMember2023-01-012023-06-300001121404sny:RestrictedSharePlan2023Membersny:WithMarketConditionMember2023-01-012023-06-300001121404sny:RestrictedSharePlan2023Membersny:ExcludingChiefExecutiveOfficerMembersny:WithMarketConditionMember2023-01-012023-06-300001121404sny:ExcludingChiefExecutiveOfficerMembersny:RestrictedSharePlan2023AdditionalSharesMembersny:WithMarketConditionMember2023-01-012023-06-300001121404sny:RestrictedSharePlan2023Membersrt:ChiefExecutiveOfficerMembersny:WithMarketConditionMember2023-01-012023-06-300001121404sny:RestrictedSharesMember2023-01-012023-06-300001121404sny:RestrictedSharesMember2022-01-012022-06-300001121404sny:RestrictedSharesMember2023-06-300001121404sny:RestrictedSharesMember2022-06-300001121404sny:RestrictedSharePlan2023Member2023-06-300001121404sny:RestrictedSharePlan2023Member2022-06-300001121404sny:RestrictedSharePlan2022Member2023-06-300001121404sny:RestrictedSharePlan2022Member2022-06-300001121404sny:RestrictedSharePlan2021Member2023-06-300001121404sny:RestrictedSharePlan2021Member2022-06-300001121404sny:RestrictedSharePlan2020Member2023-06-300001121404sny:RestrictedSharePlan2020Member2022-06-300001121404sny:EmployeeShareOwnershipPlanMember2023-02-020001121404sny:EmployeeShareOwnershipPlanMember2023-06-230001121404sny:EmployeeShareOwnershipPlanMember2023-01-012023-06-300001121404sny:EmployeeShareOwnershipPlanMember2022-02-030001121404sny:EmployeeShareOwnershipPlanMember2022-06-290001121404sny:EmployeeShareOwnershipPlanMember2022-01-012022-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeTwoMemberifrs-full:BottomOfRangeMember2023-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeTwoMemberifrs-full:TopOfRangeMember2023-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeTwoMember2023-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeTwoMember2023-01-012023-06-300001121404sny:StockOptionPlanMemberifrs-full:BottomOfRangeMembersny:ExercisePriceRangeThreeMember2023-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeThreeMemberifrs-full:TopOfRangeMember2023-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeThreeMember2023-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeThreeMember2023-01-012023-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeFourMemberifrs-full:BottomOfRangeMember2023-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeFourMemberifrs-full:TopOfRangeMember2023-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeFourMember2023-06-300001121404sny:StockOptionPlanMembersny:ExercisePriceRangeFourMember2023-01-012023-06-300001121404sny:StockOptionPlanMember2023-06-300001121404sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-06-300001121404sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-06-300001121404sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-12-310001121404sny:EquityInstrumentsIncludedInFinancialAssetsMembersny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-06-300001121404sny:EquityInstrumentsIncludedInFinancialAssetsMembersny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-06-300001121404sny:EquityInstrumentsIncludedInFinancialAssetsMembersny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-12-310001121404sny:DebtInstrumentsMembersny:ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-06-300001121404sny:DebtInstrumentsMembersny:ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-06-300001121404sny:DebtInstrumentsMembersny:ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-12-310001121404sny:ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-06-300001121404sny:ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-06-300001121404sny:ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-12-310001121404sny:CashFlowAndFairValueHedgeMembersny:ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-06-300001121404sny:CashFlowAndFairValueHedgeMembersny:ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-12-310001121404sny:CashFlowAndFairValueHedgeMembersny:ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrs-full:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-06-300001121404sny:EuroapiMember2022-01-012022-06-300001121404sny:AmortizedCostNettingMember2023-06-300001121404sny:AdjustmentToDebtMeasuredAtFairValueMember2023-06-300001121404sny:ValueOnRedemptionMember2023-06-300001121404sny:ValueOnRedemptionMember2022-12-310001121404sny:ValueOnRedemptionMembersny:NonCurrentLiabilitiesMember2023-06-300001121404sny:CurrentLiabilitiesMembersny:ValueOnRedemptionMember2023-06-300001121404sny:ValueOnRedemptionMembersny:NonCurrentLiabilitiesMember2022-12-310001121404sny:CurrentLiabilitiesMembersny:ValueOnRedemptionMember2022-12-310001121404sny:ValueOnRedemptionMembersny:NonCurrentAssetsMember2023-06-300001121404sny:ValueOnRedemptionMembersny:CurrentAssetsMember2023-06-300001121404sny:ValueOnRedemptionMembersny:NonCurrentAssetsMember2022-12-310001121404sny:ValueOnRedemptionMembersny:CurrentAssetsMember2022-12-310001121404sny:CommercialPaperProgramInUSAMembersny:CurrentLiabilitiesMembersny:ValueOnRedemptionMember2023-06-300001121404sny:CurrentLiabilitiesMembersny:CommercialPaperProgramInFranceMembersny:ValueOnRedemptionMember2023-06-30sny:bond0001121404sny:OneBillionSevenHundredFiftyMillionBondsMaturingMarch2023Member2018-03-310001121404sny:OneBillionBondsMaturingJune2023Member2018-06-300001121404sny:SyndicatedCreditFacilityOneMember2023-06-300001121404sny:SyndicatedCreditFacilityTwoMember2023-06-30sny:extension0001121404sny:SyndicatedCreditFacilityTwoMember2023-01-012023-06-300001121404sny:SyndicatedCreditFacilityCanceledMember2023-03-080001121404sny:CommercialPaperProgramInFranceMember2023-06-300001121404sny:CommercialPaperProgramInUSAMember2023-06-300001121404sny:CommercialPaperProgramInUSAMembersny:SanofiEuroMediumTermNotesMember2023-01-012023-06-300001121404sny:CommercialPaperProgramInFranceMembersny:SanofiEuroMediumTermNotesMember2023-01-012023-06-300001121404sny:AtMarketValueMember2023-06-300001121404sny:AtMarketValueMember2022-12-310001121404sny:ValueOnRedemptionMember2023-01-012023-06-300001121404sny:ValueOnRedemptionMember2022-01-012022-12-310001121404sny:ForwardCurrencySalesMembersny:AtNotionalAmountMember2023-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencySalesMember2023-06-300001121404sny:ForwardCurrencySalesMembersny:AtNotionalAmountMemberifrs-full:CashFlowHedgesMember2023-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencySalesMemberifrs-full:CashFlowHedgesMember2023-06-300001121404sny:ValueOfHedgeRecognizedInEquityMembersny:ForwardCurrencySalesMemberifrs-full:CashFlowHedgesMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencySalesMembersny:AtNotionalAmountMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMembersny:ForwardCurrencySalesMember2023-06-300001121404sny:AtNotionalAmountMembersny:ForwardCurrencySalesInUSDollarMember2023-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencySalesInUSDollarMember2023-06-300001121404sny:AtNotionalAmountMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInUSDollarMember2023-06-300001121404ifrs-full:AtFairValueMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInUSDollarMember2023-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInUSDollarMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:AtNotionalAmountMembersny:ForwardCurrencySalesInUSDollarMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMembersny:ForwardCurrencySalesInUSDollarMember2023-06-300001121404sny:AtNotionalAmountMembersny:ForwardCurrencySalesInChineseYuanRenminbiMember2023-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencySalesInChineseYuanRenminbiMember2023-06-300001121404sny:AtNotionalAmountMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInChineseYuanRenminbiMember2023-06-300001121404ifrs-full:AtFairValueMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInChineseYuanRenminbiMember2023-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInChineseYuanRenminbiMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:AtNotionalAmountMembersny:ForwardCurrencySalesInChineseYuanRenminbiMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMembersny:ForwardCurrencySalesInChineseYuanRenminbiMember2023-06-300001121404sny:AtNotionalAmountMembersny:ForwardCurrencySalesInJapaneseYenMember2023-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencySalesInJapaneseYenMember2023-06-300001121404sny:AtNotionalAmountMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInJapaneseYenMember2023-06-300001121404ifrs-full:AtFairValueMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInJapaneseYenMember2023-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInJapaneseYenMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:AtNotionalAmountMembersny:ForwardCurrencySalesInJapaneseYenMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMembersny:ForwardCurrencySalesInJapaneseYenMember2023-06-300001121404sny:AtNotionalAmountMembersny:ForwardCurrencySalesInMexicanPesoMember2023-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencySalesInMexicanPesoMember2023-06-300001121404sny:AtNotionalAmountMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInMexicanPesoMember2023-06-300001121404ifrs-full:AtFairValueMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInMexicanPesoMember2023-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInMexicanPesoMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:AtNotionalAmountMembersny:ForwardCurrencySalesInMexicanPesoMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMembersny:ForwardCurrencySalesInMexicanPesoMember2023-06-300001121404sny:AtNotionalAmountMembersny:ForwardCurrencySalesInSingaporeDollarMember2023-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencySalesInSingaporeDollarMember2023-06-300001121404sny:AtNotionalAmountMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInSingaporeDollarMember2023-06-300001121404ifrs-full:AtFairValueMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInSingaporeDollarMember2023-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencySalesInSingaporeDollarMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:AtNotionalAmountMembersny:ForwardCurrencySalesInSingaporeDollarMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMembersny:ForwardCurrencySalesInSingaporeDollarMember2023-06-300001121404sny:AtNotionalAmountMembersny:ForwardCurrencyPurchasesMember2023-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesMember2023-06-300001121404sny:AtNotionalAmountMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesMember2023-06-300001121404ifrs-full:AtFairValueMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesMember2023-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:AtNotionalAmountMembersny:ForwardCurrencyPurchasesMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesMember2023-06-300001121404sny:ForwardCurrencyPurchasesInUSDollarMembersny:AtNotionalAmountMember2023-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInUSDollarMember2023-06-300001121404sny:ForwardCurrencyPurchasesInUSDollarMembersny:AtNotionalAmountMemberifrs-full:CashFlowHedgesMember2023-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInUSDollarMemberifrs-full:CashFlowHedgesMember2023-06-300001121404sny:ValueOfHedgeRecognizedInEquityMembersny:ForwardCurrencyPurchasesInUSDollarMemberifrs-full:CashFlowHedgesMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencyPurchasesInUSDollarMembersny:AtNotionalAmountMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInUSDollarMember2023-06-300001121404sny:ForwardCurrencyPurchasesInSingaporeDollarMembersny:AtNotionalAmountMember2023-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInSingaporeDollarMember2023-06-300001121404sny:ForwardCurrencyPurchasesInSingaporeDollarMembersny:AtNotionalAmountMemberifrs-full:CashFlowHedgesMember2023-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInSingaporeDollarMemberifrs-full:CashFlowHedgesMember2023-06-300001121404sny:ValueOfHedgeRecognizedInEquityMembersny:ForwardCurrencyPurchasesInSingaporeDollarMemberifrs-full:CashFlowHedgesMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencyPurchasesInSingaporeDollarMembersny:AtNotionalAmountMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInSingaporeDollarMember2023-06-300001121404sny:AtNotionalAmountMembersny:ForwardCurrencyPurchasesInCanadianDollarMember2023-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInCanadianDollarMember2023-06-300001121404sny:AtNotionalAmountMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInCanadianDollarMember2023-06-300001121404ifrs-full:AtFairValueMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInCanadianDollarMember2023-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInCanadianDollarMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:AtNotionalAmountMembersny:ForwardCurrencyPurchasesInCanadianDollarMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInCanadianDollarMember2023-06-300001121404sny:ForwardCurrencyPurchasesInKoreanWonMembersny:AtNotionalAmountMember2023-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInKoreanWonMember2023-06-300001121404sny:ForwardCurrencyPurchasesInKoreanWonMembersny:AtNotionalAmountMemberifrs-full:CashFlowHedgesMember2023-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInKoreanWonMemberifrs-full:CashFlowHedgesMember2023-06-300001121404sny:ValueOfHedgeRecognizedInEquityMembersny:ForwardCurrencyPurchasesInKoreanWonMemberifrs-full:CashFlowHedgesMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:ForwardCurrencyPurchasesInKoreanWonMembersny:AtNotionalAmountMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInKoreanWonMember2023-06-300001121404sny:AtNotionalAmountMembersny:ForwardCurrencyPurchasesInChineseYuanRenminbiMember2023-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInChineseYuanRenminbiMember2023-06-300001121404sny:AtNotionalAmountMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInChineseYuanRenminbiMember2023-06-300001121404ifrs-full:AtFairValueMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInChineseYuanRenminbiMember2023-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMembersny:ForwardCurrencyPurchasesInChineseYuanRenminbiMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:AtNotionalAmountMembersny:ForwardCurrencyPurchasesInChineseYuanRenminbiMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInChineseYuanRenminbiMember2023-06-300001121404sny:AtNotionalAmountMember2023-06-300001121404ifrs-full:AtFairValueMember2023-06-300001121404sny:AtNotionalAmountMemberifrs-full:CashFlowHedgesMember2023-06-300001121404ifrs-full:AtFairValueMemberifrs-full:CashFlowHedgesMember2023-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMembersny:AtNotionalAmountMember2023-06-300001121404sny:NotEligibleForHedgeAccountingMemberifrs-full:AtFairValueMember2023-06-300001121404ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:AtNotionalAmountMembersny:ForwardCurrencySalesInUSDollarMember2023-06-300001121404ifrs-full:AtFairValueMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:ForwardCurrencySalesInUSDollarMember2023-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:AtNotionalAmountMembersny:ForwardCurrencySalesInSingaporeDollarMember2023-06-300001121404ifrs-full:NotLaterThanOneYearMemberifrs-full:AtFairValueMembersny:ForwardCurrencySalesInSingaporeDollarMember2023-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:ForwardCurrencySalesInPoundSterlingMembersny:AtNotionalAmountMember2023-06-300001121404ifrs-full:NotLaterThanOneYearMemberifrs-full:AtFairValueMembersny:ForwardCurrencySalesInPoundSterlingMember2023-06-300001121404sny:ForwardCurrencyPurchasesInUSDollarMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:AtNotionalAmountMember2023-06-300001121404ifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInUSDollarMemberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2023-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:ForwardCurrencyPurchasesInSingaporeDollarMembersny:AtNotionalAmountMember2023-06-300001121404ifrs-full:NotLaterThanOneYearMemberifrs-full:AtFairValueMembersny:ForwardCurrencyPurchasesInSingaporeDollarMember2023-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:ForwardCurrencyPurchasesInJapaneseYenMembersny:AtNotionalAmountMember2023-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:ForwardCurrencyPurchasesInJapaneseYenMemberifrs-full:AtFairValueMember2023-06-300001121404sny:ForwardCurrencySalesInUSDollarMember2023-06-300001121404sny:ForwardCurrencySalesInSingaporeDollarMember2023-06-30iso4217:SGD0001121404sny:ForwardCurrencyPurchasesInUSDollarUSBondMember2023-06-300001121404sny:ForwardCurrencyPurchasesInUSDollarUSBondMember2023-01-012023-06-300001121404sny:ForwardCurrencyPurchasesInUSDollarCommercialPaperMember2023-06-300001121404sny:ForwardCurrencyPurchasesInUSDollarCommercialPaperMember2023-01-012023-06-300001121404sny:ForwardCurrencyPurchasesInSingaporeDollarMember2023-06-300001121404sny:ForwardCurrencyPurchasesInSingaporeDollarMember2023-01-012023-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive103Member2023-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive103Membersny:AtNotionalAmountMember2023-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive103Memberifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:AtNotionalAmountMember2023-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive103Membersny:AtNotionalAmountMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember2023-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive103Membersny:AtNotionalAmountMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember2023-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive103Memberifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMembersny:AtNotionalAmountMember2023-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive103Membersny:AtNotionalAmountMember2023-06-300001121404ifrs-full:AtFairValueMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive103Member2023-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive103Membersny:AtNotionalAmountMemberifrs-full:FairValueHedgesMember2023-06-300001121404ifrs-full:AtFairValueMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive103Memberifrs-full:FairValueHedgesMember2023-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive103Membersny:AtNotionalAmountMemberifrs-full:CashFlowHedgesMember2023-06-300001121404ifrs-full:AtFairValueMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive103Memberifrs-full:CashFlowHedgesMember2023-06-300001121404sny:ValueOfHedgeRecognizedInEquityMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive103Memberifrs-full:CashFlowHedgesMember2023-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Member2023-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Membersny:AtNotionalAmountMember2023-06-300001121404ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Membersny:AtNotionalAmountMember2023-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Membersny:AtNotionalAmountMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember2023-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Membersny:AtNotionalAmountMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember2023-06-300001121404ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Membersny:AtNotionalAmountMember2023-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Membersny:AtNotionalAmountMember2023-06-300001121404ifrs-full:AtFairValueMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Member2023-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Membersny:AtNotionalAmountMemberifrs-full:FairValueHedgesMember2023-06-300001121404ifrs-full:AtFairValueMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Memberifrs-full:FairValueHedgesMember2023-06-300001121404sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Membersny:AtNotionalAmountMemberifrs-full:CashFlowHedgesMember2023-06-300001121404ifrs-full:AtFairValueMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Memberifrs-full:CashFlowHedgesMember2023-06-300001121404sny:ValueOfHedgeRecognizedInEquityMembersny:InterestRateSwapsPayCapitalizedSOFRUSDReceive132Memberifrs-full:CashFlowHedgesMember2023-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive069Member2023-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:AtNotionalAmountMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Member2023-06-300001121404ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:AtNotionalAmountMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Member2023-06-300001121404sny:AtNotionalAmountMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Member2023-06-300001121404sny:AtNotionalAmountMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Member2023-06-300001121404ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMembersny:AtNotionalAmountMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Member2023-06-300001121404sny:AtNotionalAmountMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Member2023-06-300001121404ifrs-full:AtFairValueMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Member2023-06-300001121404sny:AtNotionalAmountMemberifrs-full:FairValueHedgesMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Member2023-06-300001121404ifrs-full:AtFairValueMemberifrs-full:FairValueHedgesMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Member2023-06-300001121404sny:AtNotionalAmountMemberifrs-full:CashFlowHedgesMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Member2023-06-300001121404ifrs-full:AtFairValueMemberifrs-full:CashFlowHedgesMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Member2023-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMembersny:InterestRateSwapsPayCapitalizedEsterReceive069Member2023-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive092Member2023-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMember2023-06-300001121404ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMember2023-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember2023-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember2023-06-300001121404ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMember2023-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMember2023-06-300001121404ifrs-full:AtFairValueMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Member2023-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMemberifrs-full:FairValueHedgesMember2023-06-300001121404ifrs-full:AtFairValueMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Memberifrs-full:FairValueHedgesMember2023-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive092Membersny:AtNotionalAmountMemberifrs-full:CashFlowHedgesMember2023-06-300001121404ifrs-full:AtFairValueMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Memberifrs-full:CashFlowHedgesMember2023-06-300001121404sny:ValueOfHedgeRecognizedInEquityMembersny:InterestRateSwapsPayCapitalizedEsterReceive092Memberifrs-full:CashFlowHedgesMember2023-06-300001121404sny:InterestRateSwapsPayCapitalizedEsterReceive343Member2023-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:AtNotionalAmountMembersny:InterestRateSwapsPayCapitalizedEsterReceive343Member2023-06-300001121404ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:AtNotionalAmountMembersny:InterestRateSwapsPayCapitalizedEsterReceive343Member2023-06-300001121404sny:AtNotionalAmountMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMembersny:InterestRateSwapsPayCapitalizedEsterReceive343Member2023-06-300001121404sny:AtNotionalAmountMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMembersny:InterestRateSwapsPayCapitalizedEsterReceive343Member2023-06-300001121404ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMembersny:AtNotionalAmountMembersny:InterestRateSwapsPayCapitalizedEsterReceive343Member2023-06-300001121404sny:AtNotionalAmountMembersny:InterestRateSwapsPayCapitalizedEsterReceive343Member2023-06-300001121404ifrs-full:AtFairValueMembersny:InterestRateSwapsPayCapitalizedEsterReceive343Member2023-06-300001121404sny:AtNotionalAmountMembersny:InterestRateSwapsPayCapitalizedEsterReceive343Memberifrs-full:FairValueHedgesMember2023-06-300001121404ifrs-full:AtFairValueMembersny:InterestRateSwapsPayCapitalizedEsterReceive343Memberifrs-full:FairValueHedgesMember2023-06-300001121404sny:AtNotionalAmountMemberifrs-full:CashFlowHedgesMembersny:InterestRateSwapsPayCapitalizedEsterReceive343Member2023-06-300001121404ifrs-full:AtFairValueMemberifrs-full:CashFlowHedgesMembersny:InterestRateSwapsPayCapitalizedEsterReceive343Member2023-06-300001121404sny:ValueOfHedgeRecognizedInEquityMemberifrs-full:CashFlowHedgesMembersny:InterestRateSwapsPayCapitalizedEsterReceive343Member2023-06-300001121404ifrs-full:NotLaterThanOneYearMembersny:AtNotionalAmountMember2023-06-300001121404ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMembersny:AtNotionalAmountMember2023-06-300001121404sny:AtNotionalAmountMemberifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember2023-06-300001121404sny:AtNotionalAmountMemberifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember2023-06-300001121404ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMembersny:AtNotionalAmountMember2023-06-300001121404sny:AtNotionalAmountMemberifrs-full:FairValueHedgesMember2023-06-300001121404ifrs-full:AtFairValueMemberifrs-full:FairValueHedgesMember2023-06-300001121404sny:BayerContingentPurchaseConsiderationArisingFromAcquisitionOfGenzymeMember2022-12-310001121404sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember2022-12-310001121404sny:ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember2022-12-310001121404sny:ContingentConsiderationArisingFromAcquisitionOfAmunixMember2022-12-310001121404sny:OtherLiabilities1Member2022-12-310001121404sny:BayerContingentPurchaseConsiderationArisingFromAcquisitionOfGenzymeMember2023-01-012023-06-300001121404sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember2023-01-012023-06-300001121404sny:ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember2023-01-012023-06-300001121404sny:ContingentConsiderationArisingFromAcquisitionOfAmunixMember2023-01-012023-06-300001121404sny:OtherLiabilities1Member2023-01-012023-06-300001121404sny:BayerContingentPurchaseConsiderationArisingFromAcquisitionOfGenzymeMember2023-06-300001121404sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember2023-06-300001121404sny:ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember2023-06-300001121404sny:ContingentConsiderationArisingFromAcquisitionOfAmunixMember2023-06-300001121404sny:OtherLiabilities1Member2023-06-300001121404sny:BayerContingentPurchaseConsiderationArisingFromAcquisitionOfGenzymeMemberifrs-full:TopOfRangeMember2023-01-012023-06-300001121404sny:AntibodiesCollaborationAgreementMembersny:SwedishOrphanBiovitrumABMember2023-06-300001121404sny:ProvisionsForPensionsAndOtherPostemploymentBenefitsMember2022-12-310001121404sny:ProvisionsForOtherLongTermBenefitsMember2022-12-310001121404sny:NonCurrentRestructuringProvisionMember2022-12-310001121404ifrs-full:MiscellaneousOtherProvisionsMember2022-12-310001121404sny:ProvisionsForPensionsAndOtherPostemploymentBenefitsMember2023-01-012023-06-300001121404sny:ProvisionsForOtherLongTermBenefitsMember2023-01-012023-06-300001121404sny:NonCurrentRestructuringProvisionMember2023-01-012023-06-300001121404ifrs-full:MiscellaneousOtherProvisionsMember2023-01-012023-06-300001121404sny:ProvisionsForPensionsAndOtherPostemploymentBenefitsMember2023-06-300001121404sny:ProvisionsForOtherLongTermBenefitsMember2023-06-300001121404sny:NonCurrentRestructuringProvisionMember2023-06-300001121404ifrs-full:MiscellaneousOtherProvisionsMember2023-06-300001121404ifrs-full:PlanAssetsMembersny:PensionsAndOtherPostEmploymentBenefitsMember2023-01-012023-06-300001121404ifrs-full:PlanAssetsMembersny:PensionsAndOtherPostEmploymentBenefitsMember2022-01-012022-06-300001121404ifrs-full:PlanAssetsMembersny:PensionsAndOtherPostEmploymentBenefitsMember2022-01-012022-12-310001121404sny:PensionsAndOtherPostEmploymentBenefitsMember2023-01-012023-06-300001121404sny:PensionsAndOtherPostEmploymentBenefitsMember2022-01-012022-06-300001121404sny:PensionsAndOtherPostEmploymentBenefitsMember2022-01-012022-12-310001121404ifrs-full:ActuarialAssumptionOfDiscountRatesMembersrt:MinimumMember2023-06-300001121404ifrs-full:ActuarialAssumptionOfDiscountRatesMembersrt:MaximumMember2023-06-300001121404ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMembersny:EUROZONEMember2023-06-300001121404ifrs-full:ActuarialAssumptionOfDiscountRatesMembersrt:MinimumMember2022-06-300001121404ifrs-full:ActuarialAssumptionOfDiscountRatesMembersrt:MaximumMember2022-06-300001121404ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMembercountry:GB2022-06-300001121404ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMembersny:EUROZONEMember2022-06-300001121404sny:MazeTherapeuticsMember2023-05-012023-05-010001121404sny:MazeTherapeuticsMembersrt:MaximumMember2023-05-010001121404sny:ScribeTherapeuticsMember2023-06-192023-06-190001121404sny:ScribeTherapeuticsMembersrt:MaximumMember2023-06-190001121404srt:MinimumMember2023-01-012023-06-300001121404sny:ActionForWhichWeAreDefendantMembersny:PlavixAttorneyGeneralActionInHawaiiMember2023-03-012023-03-310001121404ifrs-full:OtherRelatedPartiesMembersny:OtherOperatingIncomeExpenseMember2023-01-012023-06-300001121404ifrs-full:OtherRelatedPartiesMembersny:OtherOperatingIncomeExpenseMember2022-01-012022-06-300001121404sny:RegeneronMembersny:OtherOperatingIncomeExpenseMember2023-01-012023-06-300001121404sny:RegeneronMembersny:OtherOperatingIncomeExpenseMember2022-01-012022-06-300001121404sny:CommercializationRelatedExpensesMembersny:RegeneronMemberifrs-full:OtherRelatedPartiesMember2023-01-012023-06-300001121404sny:CommercializationRelatedExpensesMembersny:RegeneronMemberifrs-full:OtherRelatedPartiesMember2022-01-012022-06-300001121404sny:AntibodiesAllianceMembersny:ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember2023-01-012023-06-300001121404sny:AntibodiesAllianceMembersny:ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember2022-01-012022-06-300001121404sny:AntibodiesAllianceMembersny:ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember2022-01-012022-12-310001121404sny:AntibodiesAllianceMembersny:ShareOfProfitOrLossFromCommercializationOfZaltrapMember2023-01-012023-06-300001121404sny:AntibodiesAllianceMembersny:ShareOfProfitOrLossFromCommercializationOfZaltrapMember2022-01-012022-06-300001121404sny:AntibodiesAllianceMembersny:ShareOfProfitOrLossFromCommercializationOfZaltrapMember2022-01-012022-12-310001121404sny:AntibodiesAllianceMembersny:CommercializationRelatedExpensesMember2023-01-012023-06-300001121404sny:AntibodiesAllianceMembersny:CommercializationRelatedExpensesMember2022-01-012022-06-300001121404sny:AntibodiesAllianceMembersny:CommercializationRelatedExpensesMember2022-01-012022-12-310001121404sny:AntibodiesAllianceMember2023-01-012023-06-300001121404sny:AntibodiesAllianceMember2022-01-012022-06-300001121404sny:AntibodiesAllianceMember2022-01-012022-12-310001121404sny:ImmunoOncologyAllianceMember2023-01-012023-06-300001121404sny:ImmunoOncologyAllianceMember2022-01-012022-06-300001121404sny:ImmunoOncologyAllianceMember2022-01-012022-12-310001121404sny:OthersCounterpartyMember2023-01-012023-06-300001121404sny:OthersCounterpartyMember2022-01-012022-06-300001121404sny:OthersCounterpartyMember2022-01-012022-12-310001121404sny:RegeneronMembersny:OtherOperatingIncomeExpenseMember2022-01-012022-12-3100011214042022-07-012023-06-300001121404sny:InterestRateAndCurrencyDerivativesMember2023-01-012023-06-300001121404sny:InterestRateAndCurrencyDerivativesMember2022-01-012022-06-300001121404sny:InterestRateAndCurrencyDerivativesMember2022-01-012022-12-310001121404srt:EuropeMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembercountry:US2023-01-012023-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMembercountry:US2022-01-012022-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:SpecialtyCareMembersrt:EuropeMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:SpecialtyCareMembersny:BiopharmaSegmentMembercountry:US2023-01-012023-06-300001121404sny:SpecialtyCareMembersny:OtherCountriesMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:SpecialtyCareMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:SpecialtyCareMembersrt:EuropeMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:SpecialtyCareMembersny:BiopharmaSegmentMembercountry:US2022-01-012022-06-300001121404sny:SpecialtyCareMembersny:OtherCountriesMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:SpecialtyCareMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:DupixentMembersrt:EuropeMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:DupixentMembersny:BiopharmaSegmentMembercountry:US2023-01-012023-06-300001121404sny:DupixentMembersny:OtherCountriesMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:DupixentMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:DupixentMembersrt:EuropeMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:DupixentMembersny:BiopharmaSegmentMembercountry:US2022-01-012022-06-300001121404sny:DupixentMembersny:OtherCountriesMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:DupixentMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:AubagioMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:AubagioMembercountry:US2023-01-012023-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:AubagioMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:AubagioMember2023-01-012023-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:AubagioMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMembersny:AubagioMembercountry:US2022-01-012022-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:AubagioMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMembersny:AubagioMember2022-01-012022-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:CerezymeMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:CerezymeMembercountry:US2023-01-012023-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:CerezymeMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:CerezymeMember2023-01-012023-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:CerezymeMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMembersny:CerezymeMembercountry:US2022-01-012022-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:CerezymeMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMembersny:CerezymeMember2022-01-012022-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:MyozymeLumizymeMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembercountry:USsny:MyozymeLumizymeMember2023-01-012023-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:MyozymeLumizymeMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:MyozymeLumizymeMember2023-01-012023-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:MyozymeLumizymeMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMembercountry:USsny:MyozymeLumizymeMember2022-01-012022-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:MyozymeLumizymeMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMembersny:MyozymeLumizymeMember2022-01-012022-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:FabrazymeMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembercountry:USsny:FabrazymeMember2023-01-012023-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:FabrazymeMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:FabrazymeMember2023-01-012023-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:FabrazymeMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMembercountry:USsny:FabrazymeMember2022-01-012022-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:FabrazymeMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMembersny:FabrazymeMember2022-01-012022-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:JevtanaMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembercountry:USsny:JevtanaMember2023-01-012023-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:JevtanaMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:JevtanaMember2023-01-012023-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:JevtanaMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMembercountry:USsny:JevtanaMember2022-01-012022-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:JevtanaMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMembersny:JevtanaMember2022-01-012022-06-300001121404sny:AlprolixMembersrt:EuropeMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:AlprolixMembersny:BiopharmaSegmentMembercountry:US2023-01-012023-06-300001121404sny:AlprolixMembersny:OtherCountriesMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:AlprolixMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:AlprolixMembersrt:EuropeMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:AlprolixMembersny:BiopharmaSegmentMembercountry:US2022-01-012022-06-300001121404sny:AlprolixMembersny:OtherCountriesMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:AlprolixMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404srt:EuropeMembersny:EloctateMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:EloctateMembersny:BiopharmaSegmentMembercountry:US2023-01-012023-06-300001121404sny:OtherCountriesMembersny:EloctateMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:EloctateMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404srt:EuropeMembersny:EloctateMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:EloctateMembersny:BiopharmaSegmentMembercountry:US2022-01-012022-06-300001121404sny:OtherCountriesMembersny:EloctateMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:EloctateMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:GeneralMedicinesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembercountry:USsny:GeneralMedicinesMember2023-01-012023-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:GeneralMedicinesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:GeneralMedicinesMember2023-01-012023-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:GeneralMedicinesMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMembercountry:USsny:GeneralMedicinesMember2022-01-012022-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:GeneralMedicinesMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMembersny:GeneralMedicinesMember2022-01-012022-06-300001121404srt:EuropeMembersny:CoreAssetsMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:CoreAssetsMembersny:BiopharmaSegmentMembercountry:US2023-01-012023-06-300001121404sny:CoreAssetsMembersny:OtherCountriesMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:CoreAssetsMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404srt:EuropeMembersny:CoreAssetsMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:CoreAssetsMembersny:BiopharmaSegmentMembercountry:US2022-01-012022-06-300001121404sny:CoreAssetsMembersny:OtherCountriesMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:CoreAssetsMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:LovenoxMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembercountry:USsny:LovenoxMember2023-01-012023-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:LovenoxMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:LovenoxMember2023-01-012023-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:LovenoxMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMembercountry:USsny:LovenoxMember2022-01-012022-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:LovenoxMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMembersny:LovenoxMember2022-01-012022-06-300001121404sny:ToujeoMembersrt:EuropeMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:ToujeoMembersny:BiopharmaSegmentMembercountry:US2023-01-012023-06-300001121404sny:ToujeoMembersny:OtherCountriesMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:ToujeoMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:ToujeoMembersrt:EuropeMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:ToujeoMembersny:BiopharmaSegmentMembercountry:US2022-01-012022-06-300001121404sny:ToujeoMembersny:OtherCountriesMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:ToujeoMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:PlavixMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:PlavixMembercountry:US2023-01-012023-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:PlavixMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:PlavixMember2023-01-012023-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:PlavixMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMembersny:PlavixMembercountry:US2022-01-012022-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:PlavixMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMembersny:PlavixMember2022-01-012022-06-300001121404srt:EuropeMembersny:NonCoreAssetsMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:NonCoreAssetsMembersny:BiopharmaSegmentMembercountry:US2023-01-012023-06-300001121404sny:OtherCountriesMembersny:NonCoreAssetsMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:NonCoreAssetsMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404srt:EuropeMembersny:NonCoreAssetsMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:NonCoreAssetsMembersny:BiopharmaSegmentMembercountry:US2022-01-012022-06-300001121404sny:OtherCountriesMembersny:NonCoreAssetsMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:NonCoreAssetsMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:LantusMembersrt:EuropeMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:LantusMembersny:BiopharmaSegmentMembercountry:US2023-01-012023-06-300001121404sny:LantusMembersny:OtherCountriesMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:LantusMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:LantusMembersrt:EuropeMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:LantusMembersny:BiopharmaSegmentMembercountry:US2022-01-012022-06-300001121404sny:LantusMembersny:OtherCountriesMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:LantusMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404srt:EuropeMembersny:OtherNonCoreAssetsMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:OtherNonCoreAssetsMembersny:BiopharmaSegmentMembercountry:US2023-01-012023-06-300001121404sny:OtherNonCoreAssetsMembersny:OtherCountriesMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:OtherNonCoreAssetsMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404srt:EuropeMembersny:OtherNonCoreAssetsMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:OtherNonCoreAssetsMembersny:BiopharmaSegmentMembercountry:US2022-01-012022-06-300001121404sny:OtherNonCoreAssetsMembersny:OtherCountriesMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:OtherNonCoreAssetsMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:IndustrialSalesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembercountry:USsny:IndustrialSalesMember2023-01-012023-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:IndustrialSalesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:IndustrialSalesMember2023-01-012023-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:IndustrialSalesMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMembercountry:USsny:IndustrialSalesMember2022-01-012022-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:IndustrialSalesMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMembersny:IndustrialSalesMember2022-01-012022-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:VaccinesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembercountry:USsny:VaccinesMember2023-01-012023-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:VaccinesMember2023-01-012023-06-300001121404sny:BiopharmaSegmentMembersny:VaccinesMember2023-01-012023-06-300001121404srt:EuropeMembersny:BiopharmaSegmentMembersny:VaccinesMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMembercountry:USsny:VaccinesMember2022-01-012022-06-300001121404sny:OtherCountriesMembersny:BiopharmaSegmentMembersny:VaccinesMember2022-01-012022-06-300001121404sny:BiopharmaSegmentMembersny:VaccinesMember2022-01-012022-06-300001121404sny:PolioPertussisHibVaccinesMembersrt:EuropeMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:PolioPertussisHibVaccinesMembersny:BiopharmaSegmentMembercountry:US2023-01-012023-06-300001121404sny:PolioPertussisHibVaccinesMembersny:OtherCountriesMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:PolioPertussisHibVaccinesMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:PolioPertussisHibVaccinesMembersrt:EuropeMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:PolioPertussisHibVaccinesMembersny:BiopharmaSegmentMembercountry:US2022-01-012022-06-300001121404sny:PolioPertussisHibVaccinesMembersny:OtherCountriesMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:PolioPertussisHibVaccinesMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404srt:EuropeMembersny:InfluenzaVaccinesMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:InfluenzaVaccinesMembersny:BiopharmaSegmentMembercountry:US2023-01-012023-06-300001121404sny:InfluenzaVaccinesMembersny:OtherCountriesMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404sny:InfluenzaVaccinesMembersny:BiopharmaSegmentMember2023-01-012023-06-300001121404srt:EuropeMembersny:InfluenzaVaccinesMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:InfluenzaVaccinesMembersny:BiopharmaSegmentMembercountry:US2022-01-012022-06-300001121404sny:InfluenzaVaccinesMembersny:OtherCountriesMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404sny:InfluenzaVaccinesMembersny:BiopharmaSegmentMember2022-01-012022-06-300001121404srt:EuropeMembersny:ConsumerHealthcareSegmentMember2023-01-012023-06-300001121404sny:ConsumerHealthcareSegmentMembercountry:US2023-01-012023-06-300001121404sny:OtherCountriesMembersny:ConsumerHealthcareSegmentMember2023-01-012023-06-300001121404srt:EuropeMembersny:ConsumerHealthcareSegmentMember2022-01-012022-06-300001121404sny:ConsumerHealthcareSegmentMembercountry:US2022-01-012022-06-300001121404sny:OtherCountriesMembersny:ConsumerHealthcareSegmentMember2022-01-012022-06-300001121404sny:ConsumerHealthcareSegmentMember2022-01-012022-06-300001121404srt:EuropeMembersny:AllergyMembersny:ConsumerHealthcareSegmentMember2023-01-012023-06-300001121404sny:AllergyMembercountry:USsny:ConsumerHealthcareSegmentMember2023-01-012023-06-300001121404sny:OtherCountriesMembersny:AllergyMembersny:ConsumerHealthcareSegmentMember2023-01-012023-06-300001121404sny:AllergyMembersny:ConsumerHealthcareSegmentMember2023-01-012023-06-300001121404srt:EuropeMembersny:AllergyMembersny:ConsumerHealthcareSegmentMember2022-01-012022-06-300001121404sny:AllergyMembercountry:USsny:ConsumerHealthcareSegmentMember2022-01-012022-06-300001121404sny:OtherCountriesMembersny:AllergyMembersny:ConsumerHealthcareSegmentMember2022-01-012022-06-300001121404sny:AllergyMembersny:ConsumerHealthcareSegmentMember2022-01-012022-06-300001121404sny:PainCareMembersrt:EuropeMembersny:ConsumerHealthcareSegmentMember2023-01-012023-06-300001121404sny:PainCareMembercountry:USsny:ConsumerHealthcareSegmentMember2023-01-012023-06-300001121404sny:PainCareMembersny:OtherCountriesMembersny:ConsumerHealthcareSegmentMember2023-01-012023-06-300001121404sny:PainCareMembersny:ConsumerHealthcareSegmentMember2023-01-012023-06-300001121404sny:PainCareMembersrt:EuropeMembersny:ConsumerHealthcareSegmentMember2022-01-012022-06-300001121404sny:PainCareMembercountry:USsny:ConsumerHealthcareSegmentMember2022-01-012022-06-300001121404sny:PainCareMembersny:OtherCountriesMembersny:ConsumerHealthcareSegmentMember2022-01-012022-06-300001121404sny:PainCareMembersny:ConsumerHealthcareSegmentMember2022-01-012022-06-300001121404srt:EuropeMembersny:DigestiveWellnessMembersny:ConsumerHealthcareSegmentMember2023-01-012023-06-300001121404sny:DigestiveWellnessMembercountry:USsny:ConsumerHealthcareSegmentMember2023-01-012023-06-300001121404sny:DigestiveWellnessMembersny:OtherCountriesMembersny:ConsumerHealthcareSegmentMember2023-01-012023-06-300001121404sny:DigestiveWellnessMembersny:ConsumerHealthcareSegmentMember2023-01-012023-06-300001121404srt:EuropeMembersny:DigestiveWellnessMembersny:ConsumerHealthcareSegmentMember2022-01-012022-06-300001121404sny:DigestiveWellnessMembercountry:USsny:ConsumerHealthcareSegmentMember2022-01-012022-06-300001121404sny:DigestiveWellnessMembersny:OtherCountriesMembersny:ConsumerHealthcareSegmentMember2022-01-012022-06-300001121404sny:DigestiveWellnessMembersny:ConsumerHealthcareSegmentMember2022-01-012022-06-300001121404srt:EuropeMember2023-01-012023-06-300001121404country:US2023-01-012023-06-300001121404sny:OtherCountriesMember2023-01-012023-06-300001121404srt:EuropeMember2022-01-012022-06-300001121404country:US2022-01-012022-06-300001121404sny:OtherCountriesMember2022-01-012022-06-300001121404ifrs-full:AllOtherSegmentsMember2023-01-012023-06-300001121404ifrs-full:ReportableSegmentsMember2023-01-012023-06-300001121404ifrs-full:AllOtherSegmentsMember2022-01-012022-06-300001121404ifrs-full:ReportableSegmentsMember2022-01-012022-06-300001121404ifrs-full:AllOtherSegmentsMember2022-01-012022-12-310001121404ifrs-full:ReportableSegmentsMember2022-01-012022-12-310001121404ifrs-full:OperatingSegmentsMember2023-01-012023-06-300001121404ifrs-full:OperatingSegmentsMember2022-01-012022-06-300001121404ifrs-full:OperatingSegmentsMember2022-01-012022-12-310001121404ifrs-full:MaterialReconcilingItemsMember2023-01-012023-06-300001121404ifrs-full:MaterialReconcilingItemsMember2022-01-012022-06-300001121404ifrs-full:MaterialReconcilingItemsMember2022-01-012022-12-310001121404sny:EloctateMember2022-01-012022-12-310001121404sny:SAR44425Memberifrs-full:OtherIntangibleAssetsMember2022-01-012022-12-310001121404sny:ImmunoOncologyCollaborationAgreementMembersny:RegeneronPharmaceuticalsIncMember2022-01-012022-12-310001121404sny:BiopharmaSegmentMember2023-06-300001121404sny:ConsumerHealthcareSegmentMember2023-06-300001121404ifrs-full:ReportableSegmentsMember2023-06-300001121404sny:BiopharmaSegmentMember2022-06-300001121404sny:ConsumerHealthcareSegmentMember2022-06-300001121404ifrs-full:ReportableSegmentsMember2022-06-300001121404sny:BiopharmaSegmentMember2022-12-310001121404sny:ConsumerHealthcareSegmentMember2022-12-310001121404ifrs-full:ReportableSegmentsMember2022-12-310001121404sny:ReportableGeographicalZonesMember2023-01-012023-06-300001121404country:FR2023-01-012023-06-300001121404srt:NorthAmericaMember2023-01-012023-06-300001121404sny:OtherCountriesExcludingEuropeAndNorthAmericaMember2023-01-012023-06-300001121404sny:ReportableGeographicalZonesMember2023-06-300001121404srt:EuropeMember2023-06-300001121404country:FR2023-06-300001121404srt:NorthAmericaMember2023-06-300001121404country:US2023-06-300001121404sny:OtherCountriesExcludingEuropeAndNorthAmericaMember2023-06-300001121404sny:ReportableGeographicalZonesMember2022-01-012022-06-300001121404country:FR2022-01-012022-06-300001121404srt:NorthAmericaMember2022-01-012022-06-300001121404sny:OtherCountriesExcludingEuropeAndNorthAmericaMember2022-01-012022-06-300001121404sny:ReportableGeographicalZonesMember2022-06-300001121404srt:EuropeMember2022-06-300001121404country:FR2022-06-300001121404srt:NorthAmericaMember2022-06-300001121404country:US2022-06-300001121404sny:OtherCountriesExcludingEuropeAndNorthAmericaMember2022-06-300001121404sny:ReportableGeographicalZonesMember2022-01-012022-12-310001121404srt:EuropeMember2022-01-012022-12-310001121404country:FR2022-01-012022-12-310001121404srt:NorthAmericaMember2022-01-012022-12-310001121404country:US2022-01-012022-12-310001121404sny:OtherCountriesExcludingEuropeAndNorthAmericaMember2022-01-012022-12-310001121404sny:ReportableGeographicalZonesMember2022-12-310001121404srt:EuropeMember2022-12-310001121404country:FR2022-12-310001121404srt:NorthAmericaMember2022-12-310001121404country:US2022-12-310001121404sny:OtherCountriesExcludingEuropeAndNorthAmericaMember2022-12-310001121404sny:CertainWholesalersInTheUnitedStatesMember2023-01-012023-06-300001121404sny:CustomerOneMember2023-01-012023-06-300001121404sny:CustomerTwoMember2023-01-012023-06-300001121404sny:CustomerThreeMember2023-01-012023-06-300001121404sny:CustomerOneMember2022-01-012022-06-300001121404sny:CustomerTwoMember2022-01-012022-06-300001121404sny:CustomerThreeMember2022-01-012022-06-300001121404sny:RecludixPharmaMembersny:MajorCollaborationAgreementMember2023-07-202023-07-200001121404sny:RecludixPharmaMembersny:MajorCollaborationAgreementMembersrt:MaximumMember2023-07-200001121404ifrs-full:MajorBusinessCombinationMembersny:QRIBIntermediateHoldingsLLCMember2023-07-27

美國
證券交易委員會
華盛頓特區 20549
 
 
表格6-K
 
 
外國私營發行人的報告
根據規則 13a-16 或 15d-16
根據1934年證券交易法
2023年7月
委員會檔案編號：001-31368
 
 
賽諾菲安萬特
(註冊單位名稱翻譯爲英文)
 
 
大軍社大街46號 – 75017 巴黎
(主要執行辦公室地址)


請使用勾選表示註冊人是否提交或將提交《20-F表格》或《40-F表格》的年度報告。
表格20-F  ☒            表格40-F  ☐




在2023年7月，賽諾菲安萬特發佈了基本報表和隨附的半年度管理報告，附在此文檔的99.1和99.2號展品中，並通過引用納入本文件。


2023 年中期財務報告

目錄

1.2
合併資產負債表 – 資產
2
合併資產負債表 — 股東權益和負債
3
合併收入表
4
綜合收益表
5
合併權益變動表
6
現金流量合併報表
9
截至2023年6月30日的濃縮半年度合併基本報表附註
11
介紹
11
A/ 半年基本報表和會計政策的編制基礎
11
B/ 2023年上半年的重要信息
15
C/ 2023年6月30日後的事件
39
2半年管理報告40
A/ 2023年上半年的重大事件
40
B/ 企業社會責任策略的實施進展44
C/ 2023年6月30日後的事件
48
D/ 2023年上半年的基本報表
49
E/ 風險因素和關聯方交易66
F/ 展望67
G/ 附錄 – 研發管道69
3法定核數師報告72
4責任聲明 – 半年財務報告73











展覽編號。描述
附件 99.1
2023年度濃縮半年度合併基本報表
附件99.2
2023年半年度管理報告、法定核數師報告及責任聲明




簽名
根據《證券交易法》的要求，申報人已經授權簽署此報告，且得到了授權。

日期：2023年7月28日
賽諾菲安萬特
作者：/s/ 亞歷山德拉·羅傑
姓名：亞歷克斯andra·羅傑
標題：證券法與資本市場部負責人